Daily Newsletter

10 August 2023

Daily Newsletter

10 August 2023

FluidAI launches new postsurgical monitor in Canada and Saudi Arabia

Utilising advanced sensors and an AI-driven algorithm, the non-invasive device enables early detection of leaks.

RanjithKumar Dharma August 10 2023

FluidAI Medical has rolled out the new artificial intelligence (AI)-powered postsurgical monitor, Stream Platform, in Saudi Arabia and Canada.

The Stream Platform's global introduction was achieved through strategic collaborations between the company, Gulf Medical and Canadian Hospital Specialties (CHS).

By utilising the Stream Platform, surgeons can precisely diagnose postoperative leaks and severe complications of digestive tract surgeries, leading to better treatment outcomes.

The new easy-to-use platform uses patient-specific data for enhancing postoperative care.

Leveraging advanced sensors and an AI-driven algorithm, the non-invasive device helps in the early detection of leaks.

It features the Origin Inline Device that collects patient data from the surgical site, as well as the Delta Bedside Monitor tablet, which analyses and shows patient data using the Stream app.

FluidAI CEO and co-founder Youssef Helwa said: “The launch of Stream Platform is a pivotal milestone in addressing the critical need we hear from surgeons across the globe: patients suffer from life-threatening complications, and we don't catch them soon enough.

“With a data-driven approach backed by artificial intelligence, we can predict complications and enable preventative medicine – an entirely new paradigm of care that is precise and tailored to individual patient needs.”

By providing data-driven solutions for healthcare providers, spanning from general to gastrointestinal surgeries, the company aims to enhance patient outcomes and advance postoperative care.

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close